Evonik, a global specialty chemicals company, has entered into a strategic distribution agreement with IMCD, a leading partner for the distribution and formulation of specialty chemicals and ingredients. Under this agreement, IMCD will serve as Evonik’s exclusive European distributor for its RESOMER® bioresorbable polymers used in implantable medical device applications. This will cover the European Economic Area countries, as well as non-members including the United Kingdom, Switzerland, Turkey, Albania, Andorra, Monaco, Montenegro, San Marino and Serbia. Set to take effect on 1 July 2025, the agreement will enable Evonik to expand its reach and better serve its customers in the market for implantable medical devices, and will allow IMCD to increase its presence in the medical devices market segment.
IMCD’s dedicated medical polymer team makes the company an ideal partner for Evonik's European customers. Adding RESOMER® medical device polymers to the IMCD medical polymer portfolio will create synergies that offer new opportunities for customers in the medical industry in various applications, such as orthopedic devices, tissue reconstruction, dental meshes and 3-D printed implantable devices.
“This partnership with IMCD will enable us to address the wide variety of customers working in the medical device space,” said Jeff Smith, Global Head of Medical Device Solutions at Evonik Health Care, “IMCD brings a team of medical polymer sales specialists who we can rely on to accelerate further business growth.”
Jana Zietzling, Head of Product Management Medical of IMCD Advanced Materials, said, “We are excited to expand our partnership with Evonik for their RESOMER® polymers for medical devices. By leveraging our shared commitment to innovation and our in-depth knowledge of medical polymers and applications, we will be able to support customers even better in the development of medical devices.”
In 2023, IMCD added a number of Evonik’s high performance polymers to its offering, including VESTAKEEP®, VESTAMID®, TROGAMID® and VESTODUR® grades. As a result of the agreement, IMCD will now provide a broad portfolio of Evonik’s biomaterials.
The distribution agreement covers the European Economic Area, the UK, Switzerland, and Turkey.
